235 related articles for article (PubMed ID: 12752593)
1. Granule protein changes and membrane receptor phenotype in maturing human eosinophils cultured from CD34+ progenitors.
Al-Rabia MW; Blaylock MG; Sexton DW; Thomson L; Walsh GM
Clin Exp Allergy; 2003 May; 33(5):640-8. PubMed ID: 12752593
[TBL] [Abstract][Full Text] [Related]
2. Immunofluorescence analysis of cytokine and granule protein expression during eosinophil maturation from cord blood-derived CD34 progenitors.
Mahmudi-Azer S; Velazquez JR; Lacy P; Denburg JA; Moqbel R
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1178-84. PubMed ID: 10856153
[TBL] [Abstract][Full Text] [Related]
3. Growth and differentiation of eosinophils from human peripheral blood CD 34+ cells.
Shalit M
Allerg Immunol (Paris); 1997 Jan; 29(1):7-10. PubMed ID: 9025988
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of eosinophil peroxidase and major basic protein messenger RNAs during eosinophil maturation.
Gruart V; Truong MJ; Plumas J; Zandecki M; Kusnierz JP; Prin L; Vinatier D; Capron A; Capron M
Blood; 1992 May; 79(10):2592-7. PubMed ID: 1375105
[TBL] [Abstract][Full Text] [Related]
5. Receptor expression and functional status of cultured human eosinophils derived from umbilical cord blood mononuclear cells.
Walsh GM; Hartnell A; Moqbel R; Cromwell O; Nagy L; Bradley B; Furitsu T; Ishizaka T; Kay AB
Blood; 1990 Jul; 76(1):105-11. PubMed ID: 1973060
[TBL] [Abstract][Full Text] [Related]
6. Evidence for local eosinophil differentiation within allergic nasal mucosa: inhibition with soluble IL-5 receptor.
Cameron L; Christodoulopoulos P; Lavigne F; Nakamura Y; Eidelman D; McEuen A; Walls A; Tavernier J; Minshall E; Moqbel R; Hamid Q
J Immunol; 2000 Feb; 164(3):1538-45. PubMed ID: 10640772
[TBL] [Abstract][Full Text] [Related]
7. Early commitment to the eosinophil lineage by cultured human peripheral blood CD34+ cells: messenger RNA analysis.
Shalit M; Sekhsaria S; Mauhorter S; Mahanti S; Malech HL
J Allergy Clin Immunol; 1996 Aug; 98(2):344-54. PubMed ID: 8757212
[TBL] [Abstract][Full Text] [Related]
8. Eosinophils maintain their capacity to signal and release eosinophil cationic protein upon repetitive stimulation with the same agonist.
Simon HU; Weber M; Becker E; Zilberman Y; Blaser K; Levi-Schaffer F
J Immunol; 2000 Oct; 165(7):4069-75. PubMed ID: 11034418
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-4 and RANTES expression in maturing eosinophils derived from human cord blood CD34+ progenitors.
Velazquez JR; Lacy P; Mahmudi-Azer S; Bablitz B; Milne CD; Denburg JA; Moqbel R
Immunology; 2000 Nov; 101(3):419-25. PubMed ID: 11106947
[TBL] [Abstract][Full Text] [Related]
10. The effects of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 on the secretory capacity of human blood eosinophils.
Tai PC; Spry CJ
Clin Exp Immunol; 1990 Jun; 80(3):426-34. PubMed ID: 2197048
[TBL] [Abstract][Full Text] [Related]
11. Down-regulated IL-5 receptor expression on peripheral blood eosinophils from budesonide-treated children with asthma.
Hellman C; Lönnkvist K; Hedlin G; Halldén G; Lundahl J
Allergy; 2002 Apr; 57(4):323-8. PubMed ID: 11906363
[TBL] [Abstract][Full Text] [Related]
12. The CCR3 receptor is involved in eosinophil differentiation and is up-regulated by Th2 cytokines in CD34+ progenitor cells.
Lamkhioued B; Abdelilah SG; Hamid Q; Mansour N; Delespesse G; Renzi PM
J Immunol; 2003 Jan; 170(1):537-47. PubMed ID: 12496441
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of a human eosinophilic leukemic cell line, EoL-1: characterization by the expression of cytokine receptors, adhesion molecules, CD95 and eosinophilic cationic protein (ECP).
Wong CK; Ho CY; Lam CW; Zhang JP; Hjelm NM
Immunol Lett; 1999 Jun; 68(2-3):317-23. PubMed ID: 10424438
[TBL] [Abstract][Full Text] [Related]
14. Quantitative, rather than qualitative, differences in CD69 upregulation in human blood eosinophils upon activation with selected stimuli.
Nopp A; Lundahl J; Halldén G
Allergy; 2000 Feb; 55(2):148-56. PubMed ID: 10726729
[TBL] [Abstract][Full Text] [Related]
15. Effects of rapamycin, cyclosporin A, and dexamethasone on interleukin 5-induced eosinophil degranulation and prolonged survival.
Meng Q; Ying S; Corrigan CJ; Wakelin M; Assoufi B; Moqbel R; Kay AB
Allergy; 1997 Nov; 52(11):1095-101. PubMed ID: 9404561
[TBL] [Abstract][Full Text] [Related]
16. Development and functional analysis of eosinophils from murine embryonic stem cells.
Hamaguchi-Tsuru E; Nobumoto A; Hirose N; Kataoka S; Fujikawa-Adachi K; Furuya M; Tominaga A
Br J Haematol; 2004 Mar; 124(6):819-27. PubMed ID: 15009071
[TBL] [Abstract][Full Text] [Related]
17. Eosinophil granule proteins in peripheral blood granulocytes.
Abu-Ghazaleh RI; Dunnette SL; Loegering DA; Checkel JL; Kita H; Thomas LL; Gleich GJ
J Leukoc Biol; 1992 Dec; 52(6):611-8. PubMed ID: 1464733
[TBL] [Abstract][Full Text] [Related]
18. Release of granule proteins from human eosinophils stimulated with mast-cell mediators.
Takafuji S; Tadokoro K; Ito K; Nakagawa T
Allergy; 1998 Oct; 53(10):951-6. PubMed ID: 9821474
[TBL] [Abstract][Full Text] [Related]
19. Release of granule proteins from eosinophils cultured with IL-5.
Kita H; Weiler DA; Abu-Ghazaleh R; Sanderson CJ; Gleich GJ
J Immunol; 1992 Jul; 149(2):629-35. PubMed ID: 1624806
[TBL] [Abstract][Full Text] [Related]
20. Gene expression accompanied by differentiation of cord blood-derived CD34+ cells to eosinophils.
Hashida R; Ogawa K; Miyagawa M; Sugita Y; Matsumoto K; Akasawa A; Saito H
Int Arch Allergy Immunol; 2001; 125 Suppl 1():2-6. PubMed ID: 11408763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
